Post Marketing Surveillance on Long-term Use With Norditropin® (Short

See also
Status	Clinical Trial	Phase
Completed	`NCT01734486` - Growth Response in Girls With Turner Syndrome	Phase 4
Completed	`NCT01529944` - Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658	Phase 3
Completed	`NCT01518036` - Use of Somatropin in Turner Syndrome	Phase 3
Completed	`NCT00025870` - Studies of Children With Metabolic and Other Genetic Disorders
Completed	`NCT01563926` - Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency	Phase 3
Active, not recruiting	`NCT01851447` - Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy
Completed	`NCT01435629` - A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin	N/A
Completed	`NCT01245374` - Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents	Phase 4
Terminated	`NCT01135537` - Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants	Phase 2
Completed	`NCT00705172` - Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
Completed	`NCT01518062` - Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome	Phase 4
Recruiting	`NCT02769949` - Pediatric Patients With Metabolic or Other Genetic Disorders
Terminated	`NCT00358657` - Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders	Phase 2
Completed	`NCT01604161` - Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome	N/A
Completed	`NCT01516229` - Special Survey for Long Term Application	N/A
Recruiting	`NCT03093220` - Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis	N/A
Enrolling by invitation	`NCT04681781` - SLC13A5 Deficiency Natural History Study - Remote Only
Completed	`NCT01529840` - Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome	Phase 3
Completed	`NCT01710696` - Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome	Phase 3
Completed	`NCT01401244` - Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers	Phase 1

NCT number	NCT03435627
Study type	Observational
Source	Novo Nordisk A/S
Contact
Status	Completed
Phase
Start date	February 26, 2018
Completion date	January 18, 2022

Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms